The call from the UK Government came in the late afternoon of Friday the 13th of March. Faced with the biggest health crisis in living memory, there was a risk that the nation’s ventilator capacity would be overwhelmed. This is the story of our response.
We began our relationship with Saranas back in 2015, as the Texas-based start-up set out on its mission to improve patient outcomes by detecting internal bleeding complications early. Half a decade on, we’re proud of our contribution to its Early Bird Bleed Monitoring System.
The resources needed by the world to store and compute data in the age of AI will vastly exceed availability if limited to conventional technologies.
Consumer demand for personalization is growing rapidly in cosmetics and skincare. With so many options, it can be hard for people to choose the right products and for brands to understand their performance.
Chiesi Farmaceutici came to us with the brief of creating a novel, next-generation dry powder inhaler (DPI) that could compete with the market leaders. In 2013, that vision was realised as NEXThaler launched in Germany. Since then, millions of units have been sold throughout Europe, with distribution continuing to expand globally.